XML 74 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement of Shareholders' Equity (USD $)
In Millions, except Share data
Total
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interests
Common Stock [Member]
Balance at beginning of period at Dec. 31, 2010 $ (2.8) $ 2,872.9 $ (2,818.4) $ 0.5 $ (141.8) $ 83.0 $ 1.0
Balance at beginning of period, shares at Dec. 31, 2010             93,400,000
Net income 254.6   208.7        
Net income attributable to nonredeemable noncontrolling interest 42.3         42.3  
Net income, including portion attributable to nonredeemable noncontrolling interest 251.0            
Convertible perpetual preferred stock dividends (26.0) (26.0)          
Stock-based compensation 20.3 20.3          
Distributions declared (40.5)         (40.5)  
Other (1.0) 6.9   (0.7) (7.0) (0.2)  
Other, Shares             1,800,000
Balance at end of period at Dec. 31, 2011 201.0 2,874.1 (2,609.7) (0.2) (148.8) 84.6 1.0
Balance at end of period, shares at Dec. 31, 2011             95,200,000
Net income 235.9   185.0        
Net income attributable to nonredeemable noncontrolling interest 47.1         47.1  
Net income, including portion attributable to nonredeemable noncontrolling interest 232.1            
Receipt of treasury stock (11.9)       (11.9)    
Receipt of treasury stock, shares             (700,000)
Convertible perpetual preferred stock dividends (23.9) (23.9)          
Stock-based compensation 24.1 24.1          
Distributions declared (45.4)         (45.4)  
Capital contributions from consolidated affiliates 12.4         12.4  
Consolidation of St. Vincent Rehabilitation Hospital 13.9         13.9  
Other 1.2 2.3   1.6 (2.6) (0.1)  
Other, Shares             1,200,000
Balance at end of period at Dec. 31, 2012 403.5 2,876.6 (2,424.7) 1.4 (163.3) 112.5 1.0
Balance at end of period, shares at Dec. 31, 2012             95,700,000
Net income 381.4   323.6        
Net income attributable to nonredeemable noncontrolling interest 52.0         52.0  
Net income, including portion attributable to nonredeemable noncontrolling interest 375.6            
Receipt of treasury stock (5.8)       (5.8)    
Receipt of treasury stock, shares             (300,000)
Dividends declared on common stock (32.0) (32.0)          
Convertible perpetual preferred stock dividends (21.0) (21.0)          
Stock-based compensation 24.8 24.8          
Stock options exercised 8.2 8.2          
Sock options exercised, Shares 338,000           300,000
Stock warrants exercised 15.3 15.3          
Stock warrants exercised, Shares             500,000
Distributions declared (40.4)         (40.4)  
Repurchase of common stock through tender offer (234.1)       (234.1)    
Repurchase of common stock through tender offer, Shares (9,100,000)            
Repurchase of preferred stock through convertible exchange (71.6) (71.6)          
Equity portion of convertible debt 71.0 71.0          
Tax impact of equity portion of convertible debt (28.0) (28.0)          
Other 3.2 6.1   (1.5) (1.4)    
Other, Shares             900,000
Balance at end of period at Dec. 31, 2013 $ 468.7 $ 2,849.4 $ (2,101.1) $ (0.1) $ (404.6) $ 124.1 $ 1.0
Balance at end of period, shares at Dec. 31, 2013             88,000,000